Viewing Study NCT06760702


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2025-12-26 @ 2:59 AM
Study NCT ID: NCT06760702
Status: RECRUITING
Last Update Posted: 2025-01-07
First Post: 2024-11-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients with Colorectal, Ovarian, and Renal Cancers
Sponsor: Aurigene Discovery Technologies Limited
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-11-09
Start Date Type: ACTUAL
Primary Completion Date: 2026-09-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-05-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-11-07
First Submit QC Date: None
Study First Post Date: 2025-01-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-03
Last Update Post Date: 2025-01-07
Last Update Post Date Type: ACTUAL